Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:56 AM
Ignite Modification Date:
2025-12-25 @ 3:56 AM
NCT ID:
NCT04230902
Eligibility Criteria:
Inclusion Criteria:
* Patients who are ≥ 45 years old
* Symptomatic knee OA defined as symptoms of knee pain and/or decreased range of motion (ROM)
* Classified radiographically as having Grade 2 or 3 Knee OA
* Failure of 3-months conservative management (NSAIDs and Physical therapy)
Exclusion Criteria:
* Patients \< 45 years old
* Pregnant or breastfeeding women
* Cancer patients
* Rheumatoid arthritis patients
* Patients having any autoimmune disease affecting the joint
* Patients who have had hyaluronic acid injection \<1 year ago
* Patients who have undergone lower extremity surgery or trauma on the same side
* Hypersensitivity to methylprednisolone (Depo-Medrol®)or any of its components, lidocaine/xylocaine or any of its components, and any of the ingredients of Lipogems® injection kit
* Patients with acute systemic or local infection
* Patients on anticoagulants (warfarin, coumadin, heparin, Xeralto, or Plavix)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
45 Years
Study:
NCT04230902
Study Brief:
Protocol Section:
NCT04230902